- $82.47m
- $104.93m
- CNY40.60m
- 24
- 18
- 31
- 13
Annual balance sheet for Nano Labs, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 35.3 | 266 | 87.8 | 48.2 | 32.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7.34 | 33.1 | 23.7 | 35.8 | 51.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 59 | 893 | 289 | 125 | 367 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.84 | 16.4 | 29.9 | 177 | 203 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 61.5 | 910 | 367 | 350 | 616 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 110 | 932 | 184 | 243 | 209 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 110 | 934 | 203 | 365 | 385 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -48.5 | -24.7 | 164 | -14.7 | 231 |
| Total Liabilities & Shareholders' Equity | 61.5 | 910 | 367 | 350 | 616 |
| Total Common Shares Outstanding |